Exelixis (EXEL) PT Lowered to $35 at UBS, Upcoming Zanza Data Expected to Disappoint
Tweet Send to a Friend
UBS analyst Ashwani Verma lowered the price target on Exelixis (NASDAQ: EXEL) to $35.00 (from $38.00) while maintaining a Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
